Spineguard (ALSGD) - Total Assets
Based on the latest financial reports, Spineguard (ALSGD) holds total assets worth €8.35 Million EUR (≈ $9.76 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ALSGD total equity for net asset value and shareholders' equity analysis.
Spineguard - Total Assets Trend (2010–2024)
This chart illustrates how Spineguard's total assets have evolved over time, based on quarterly financial data.
Spineguard - Asset Composition Analysis
Current Asset Composition (December 2024)
Spineguard's total assets of €8.35 Million consist of 37.1% current assets and 62.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 8.7% |
| Accounts Receivable | €653.63K | 7.9% |
| Inventory | €861.83K | 10.5% |
| Property, Plant & Equipment | €387.37K | 4.7% |
| Intangible Assets | €1.42 Million | 17.3% |
| Goodwill | €3.08 Million | 37.5% |
Asset Composition Trend (2010–2024)
This chart illustrates how Spineguard's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALSGD company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Spineguard's current assets represent 37.1% of total assets in 2024, a decrease from 44.9% in 2010.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2024, down from 31.1% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 53.0% in 2010.
- Asset Diversification: The largest asset category is goodwill at 37.5% of total assets.
Spineguard Competitors by Total Assets
Key competitors of Spineguard based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.12 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$20.81 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Ok Biotech Co Ltd
TW:4155
|
Taiwan | NT$3.89 Billion |
|
Promimic AB
ST:PRO
|
Sweden | Skr75.71 Million |
|
Memphasys Ltd
AU:MEM
|
Australia | AU$10.45 Million |
Spineguard - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 1.34 | 0.54 |
| Quick Ratio | 0.82 | 1.01 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €206.57K | €1.02 Million | €-2.88 Million |
Spineguard - Advanced Valuation Insights
This section examines the relationship between Spineguard's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.91 |
| Latest Market Cap to Assets Ratio | 1.33 |
| Asset Growth Rate (YoY) | -25.4% |
| Total Assets | €8.23 Million |
| Market Capitalization | $10.98 Million USD |
Valuation Analysis
Above Book Valuation: The market values Spineguard's assets above their book value (1.33x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Spineguard's assets decreased by 25.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Spineguard (2010–2024)
The table below shows the annual total assets of Spineguard from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €8.23 Million ≈ $9.62 Million |
-25.43% |
| 2023-12-31 | €11.04 Million ≈ $12.90 Million |
-4.07% |
| 2022-12-31 | €11.50 Million ≈ $13.45 Million |
-3.33% |
| 2021-12-31 | €11.90 Million ≈ $13.91 Million |
+47.65% |
| 2020-12-31 | €8.06 Million ≈ $9.42 Million |
-5.15% |
| 2019-12-31 | €8.50 Million ≈ $9.93 Million |
+8.14% |
| 2018-12-31 | €7.86 Million ≈ $9.19 Million |
-3.63% |
| 2017-12-31 | €8.15 Million ≈ $9.53 Million |
-13.36% |
| 2016-12-31 | €9.41 Million ≈ $11.00 Million |
-5.12% |
| 2015-12-31 | €9.92 Million ≈ $11.60 Million |
+15.87% |
| 2014-12-31 | €8.56 Million ≈ $10.01 Million |
-31.05% |
| 2013-12-31 | €12.41 Million ≈ $14.51 Million |
+53.39% |
| 2012-12-31 | €8.09 Million ≈ $9.46 Million |
-2.29% |
| 2011-12-31 | €8.28 Million ≈ $9.68 Million |
+11.64% |
| 2010-12-31 | €7.42 Million ≈ $8.67 Million |
-- |
About Spineguard
SpineGuard SA provides designs, develops, and markets medical devices for spine in France and internationally. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, psifguard, and threaded PediGuard products; and DSG smart screw that allows for one step screw placement treatment. It also provides DSG (Dynamic Surgical Guidance) Connect app that allows collecti… Read more